Nitrofurantoin capsules
Reason category: Dissolution failure
FDA recall number D-0168-2025
Antibiotic
Nitrofurantoin monohydrate/macro 100 mg
Public data on nitrofurantoin from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.2719
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-53%
change over five years
peak $1.8159 in 2014-04
37
approved generic applications (ANDAs) on record for Nitrofurantoin
24 with a product still marketed · first 1970
Not listed
in FDA's current shortage list
Nitrofurantoin Oral Suspension: To Be Discontinued
NADAC per unit, monthly
NITROFURANTOIN MONO-MCR 100 MGShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 1.76124 |
| 2014-02 | 1.78829 |
| 2014-05 | 1.77431 |
| 2014-08 | 1.74784 |
| 2014-11 | 1.62234 |
| 2015-02 | 1.61681 |
| 2015-05 | 1.54895 |
| 2015-08 | 1.48683 |
| 2015-11 | 1.42231 |
| 2016-02 | 1.34411 |
| 2016-05 | 1.32089 |
| 2016-08 | 1.19692 |
| 2016-11 | 1.09275 |
| 2017-02 | 0.90406 |
| 2017-05 | 0.84731 |
| 2017-08 | 0.79936 |
| 2017-11 | 0.87078 |
| 2018-02 | 0.81519 |
| 2018-05 | 0.77402 |
| 2018-08 | 0.81518 |
| 2018-11 | 0.67568 |
| 2019-02 | 0.69656 |
| 2019-05 | 0.64221 |
| 2019-08 | 0.64511 |
| 2019-11 | 0.61103 |
| 2020-02 | 0.63568 |
| 2020-05 | 0.63352 |
| 2020-08 | 0.64955 |
| 2020-11 | 0.59795 |
| 2021-02 | 0.59079 |
| 2021-05 | 0.59631 |
| 2021-08 | 0.58969 |
| 2021-11 | 0.57366 |
| 2022-02 | 0.50120 |
| 2022-05 | 0.45937 |
| 2022-08 | 0.43273 |
| 2022-11 | 0.42260 |
| 2023-02 | 0.41845 |
| 2023-05 | 0.43561 |
| 2023-08 | 0.40133 |
| 2023-11 | 0.52826 |
| 2024-02 | 0.53565 |
| 2024-05 | 0.40342 |
| 2024-08 | 0.46063 |
| 2024-11 | 0.30264 |
| 2025-02 | 0.29631 |
| 2025-05 | 0.32868 |
| 2025-08 | 0.34364 |
| 2025-11 | 0.34318 |
| 2026-02 | 0.34147 |
| 2026-05 | 0.32365 |
| 2026-08 | 0.29967 |
| 2026-11 | 0.27192 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning nitrofurantoin
openFDA enforcement records, by year reported.
| 2025 | 1 |
| 2024 | 1 |
| 2022 | 1 |
| 2021 | 2 |
| 2019 | 2 |
| 2018 | 5 |
| 2016 | 1 |
| 2015 | 2 |
| 2014 | 2 |
17 records since 2012. A record is one product or lot, not one recall event. Combination products that contain nitrofurantoin are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Nitrofurantoin product
Reason category: Dissolution failure
FDA recall number D-0597-2024
Nitrofurantoin capsules
Reason category: Labeling or packaging error
FDA recall number D-0880-2022
Nitrofurantoin product
Reason category: cGMP deviations
FDA recall number D-0421-2021
Nitrofurantoin capsules usp
Reason category: Dissolution failure
FDA recall number D-0232-2021
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention nitrofurantoin
5 GxRadar articles cite or discuss this drug.
Price histories · Data story · 5 min
Nitrofurantoin and the antibiotic price story
Pharmacies paid $1.77 for a nitrofurantoin capsule in January 2014 and 28 cents in October 2026. How six oral antibiotics' prices diverged, why competition explains much of it, and where shortages fit.
Causes & tracking · Explainer · 6 min
Why antibiotics keep running short
Seven anti-infectives were on FDA's current shortage list in October 2026, one of them since 2015, and 30 more had discontinuation notices. Low prices and few makers explain much of it, federal research shows.
Manufacturing quality · Explainer · 6 min
Dissolution testing, the lab check behind many tablet recalls
How a dissolution test measures whether a pill releases its drug, how USP and FDA set the pass mark, and what 414 recall records citing dissolution show about which products fail.
Price histories · Data story · 5 min
The cheapest pills in GxRadar's 47-drug price basket
Seven of the 47 generics we track cost pharmacies under 2 cents a unit in October 2026, led by amlodipine at 1.02 cents. Which drugs sit at the floor, how long they have been there, and what the ranking does not show.
Market economics · Explainer · 6 min
The economics of making a generic
What it costs to bring a generic to market and make it, how competition drives the price down, and why federal analyses find many launches unprofitable years later, using ASPE, FDA and NADAC data.